Alvocidib and cytarabine/mitoxantrone versus cytarabine/mitoxantrone in adults with relapsed/refractory AML with NOXA BH3 priming of ≥40% by mitochondrial profiling in bone marrow. This evidence concerns the gene PMAIP1 and acute myeloid leukemia.